Related Experiment Videos
Brain serotonin subsystem complexity and receptor heterogeneity: therapeutic potential of selective serotonin
K P Lesch1, C S Aulakh, D L Murphy
1Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term administration of m-chlorophenylpiperazine to rats does not alter functional sensitivity of either pre-synaptic or postsynaptic 5-HT1A receptors.
Journal of psychopharmacology (Oxford, England)·2012
Differential effect of lithium treatment on fenfluramine-induced decreases in food intake and locomotor activity in rats.
Journal of psychopharmacology (Oxford, England)·2012
Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats.
The Journal of pharmacology and experimental therapeutics·1996
Long-term antidepressant treatment restores clonidine's effect on growth hormone secretion in a genetic animal model of depression.
Pharmacology, biochemistry, and behavior·1996
NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats.
European journal of pharmacology·1996
Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group.
Psychopharmacology series·1993
RORα as a Context-Dependent Transcriptional Stabilizer in the Nervous System.
Neuroscience and biobehavioral reviews·2026
Lesional hair lipidomic signatures reveal ARA-LTB4 pathway activation and NETs formation in hidradenitis suppurativa.
The Journal of investigative dermatology·2026
Network pharmacological combined with in vivo and in vitro validation reveals the mechanisms of atrazine-induced Parkinson's disease-related neurotoxicity.
Toxicology and applied pharmacology·2026
Targeting TLR4/NF-κB/NLRP3 signaling with 6-hydroxyflavanone mitigates amyloid-β-induced Alzheimer's disease in mice.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026